Journal Home
Search for

Volume 93, Issue 2, Pages 447-454 (15 January 2010)


View previous. 22 of 56 View next.

Female obesity impairs in vitro fertilization outcome without affecting embryo quality

José Bellver, M.D.Corresponding Author Informationemail address, Yanira Ayllón, M.D., Marcos Ferrando, M.D., Marco Melo, M.D., Eduardo Goyri, M.D., Antonio Pellicer, M.D., José Remohí, M.D., Marcos Meseguer, Ph.D.

Received 5 August 2008; received in revised form 4 December 2008; accepted 11 December 2008. published online 27 January 2009.

Objective

To compare embryo quality and reproductive outcome in our IVF program according to the women's body mass index (BMI).

Design

Retrospective study.

Setting

University-affiliated infertility clinic, between January 2001 and April 2007.

Patient(s)

Women undergoing a total of 6,500 IVF–intracytoplasmic sperm injection (ICSI) cycles.

Intervention(s)

Six thousand five hundred IVF-ICSI cycles were included and divided into four groups: lean (<20 kg/m2; n = 1,070; 16.5%); normal (20–24.9 kg/m2; n = 3,930; 60.5%); overweight (25–29.9 kg/m2; n = 1,081; 16.6%); and obese (≥30 kg/m2; n = 419; 6.4%).

Main Outcome Measure(s)

Comparison of embryo quality and reproductive outcome (implantation, pregnancy, miscarriage, and live birth rates) among BMI groups.

Result(s)

No difference in insemination procedure, fertilization rate, day of ET, mean number of transferred and cryopreserved embryos, percentage of blastocyst transfers, or embryo quality on day 2 and 3 was found among groups. However, implantation, pregnancy, and live birth rates were poorer in obese women. In fact, pregnancy and live birth rates were reduced progressively with each unit of BMI (kilograms per square meter) with a significant odds ratio of 0.984 (95% confidence interval 0.972–0.997) and 0.981 (95% confidence interval 0.967–0.995), respectively. In addition, the cumulative pregnancy rate after four IVF cycles was reduced as BMI increased.

Conclusion(s)

Female obesity impairs IVF outcome, but embryo quality is not affected, pointing to an alteration in the uterine environment.

Instituto Valenciano de Infertilidad, University of Valencia, Valencia, Spain

Corresponding Author InformationReprint requests: José Bellver, M.D., Instituto Valenciano de Infertilidad, Plaza de la Policía Local, 3, 46015 Valencia, Spain (FAX: 34963050999).

 J.B. has nothing to disclose. Y.A. has nothing to disclose. M.F. has nothing to disclose. M.A.M.B. has nothing to disclose. E.G. has nothing to disclose. A.P. has nothing to disclose. J.R. has nothing to disclose. M.M. has nothing to disclose.

PII: S0015-0282(08)04722-5

doi:10.1016/j.fertnstert.2008.12.032


View previous. 22 of 56 View next.